KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) FCF Margin (2016 - 2025)

Quest Diagnostics' FCF Margin history spans 17 years, with the latest figure at 16.57% for Q4 2025.

  • For Q4 2025, FCF Margin rose 356.0% year-over-year to 16.57%; the TTM value through Dec 2025 reached 17.09%, up 788.0%, while the annual FY2025 figure was 17.09%, 788.0% up from the prior year.
  • FCF Margin for Q4 2025 was 16.57% at Quest Diagnostics, down from 19.99% in the prior quarter.
  • Across five years, FCF Margin topped out at 23.71% in Q1 2021 and bottomed at 1.42% in Q1 2023.
  • The 5-year median for FCF Margin is 14.64% (2021), against an average of 13.95%.
  • The largest annual shift saw FCF Margin soared 1471bps in 2021 before it plummeted -1980bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 12.28% in 2021, then rose by 17bps to 14.32% in 2022, then surged by 39bps to 19.89% in 2023, then crashed by -35bps to 13.01% in 2024, then grew by 27bps to 16.57% in 2025.
  • Per Business Quant, the three most recent readings for DGX's FCF Margin are 16.57% (Q4 2025), 19.99% (Q3 2025), and 19.7% (Q2 2025).